Key Market Indicators
Austrian insulin imports are projected to decline to approximately $32.3 million by 2028, down from $33.4 million in 2023. This marks a year-on-year compound annual growth rate (CAGR) decrease of 0.7%. Since 1999, the demand for insulin in Austria has seen a year-on-year decline of 1.4%. On the export front, Austria saw its insulin exports rise to around $842,650 in 2018, up from $834,730 in 2017. This represents a 1% increase compared to the previous year. Notably, since 1999, Austrian insulin supply has experienced a robust annual growth of 20.3%.
